Canary Medical

Canary Medical is a pioneering medical data company focused on improving healthcare outcomes through the use of implantable medical devices. Operating in the healthcare technology market, Canary Medical serves patients, healthcare providers, and medical institutions by providing advanced solutions that integrate with standard medical devices to collect and analyze data on patient mobility and health conditions.

The company's core product, Canturio™, is a SMART medical device designed to give medical implants a 'voice' by enabling them to communicate objective data remotely. This data is then aggregated, analyzed, and made accessible through Canary's wholly-owned subsidiary, Summatix™, which specializes in data management. This platform ensures that the raw sensor data collected from implants is clinically relevant and available to both patients and healthcare providers.

Canary Medical's business model revolves around the development, manufacturing, and sale of these innovative medical devices, as well as the provision of data management services. Revenue is generated through the sale of Canturio™ devices and subscription fees for data management services provided by Summatix™.

The company operates in a highly regulated market and has secured over 80 granted and pending patents, underscoring its commitment to innovation and regulatory compliance. Canary Medical's first product, the Canturio™ TE, is a modified tibial extension for use with Zimmer Persona prosthetic knee joints and has been designated a Breakthrough Device by the FDA.

Keywords: implantable devices, healthcare outcomes, real-time data, SMART medical devices, patient mobility, data analysis, Summatix™, Canturio™, FDA Breakthrough Device, medical technology.